The University of Chicago Header Logo

Connection

John Fung to Postoperative Complications

This is a "connection" page, showing publications John Fung has written about Postoperative Complications.
Connection Strength

2.994
  1. Liver transplantation for fatty liver disease. J Dig Dis. 2011 Feb; 12(1):36-7.
    View in: PubMed
    Score: 0.179
  2. Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome. Liver Transpl. 2009 Nov; 15(11):1448-57.
    View in: PubMed
    Score: 0.164
  3. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008 Oct; 14(10):1406-11.
    View in: PubMed
    Score: 0.152
  4. Is adult-to-adult living donor liver transplantation a viable option for liver replacement? Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):70-1.
    View in: PubMed
    Score: 0.126
  5. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
    View in: PubMed
    Score: 0.126
  6. Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice). Liver Transpl. 2005 Aug; 11(8):861-71.
    View in: PubMed
    Score: 0.122
  7. De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl. 2004 Jan; 10(1):1-6.
    View in: PubMed
    Score: 0.109
  8. Alcoholic liver disease and transplantation. Transplant Proc. 2003 Feb; 35(1):358-60.
    View in: PubMed
    Score: 0.103
  9. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.100
  10. Experiences relating to management of biliary tract complications following liver transplantation in 96 cases. Chin Med J (Engl). 2002 Oct; 115(10):1533-7.
    View in: PubMed
    Score: 0.100
  11. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl. 2002 Jan; 8(1):40-6.
    View in: PubMed
    Score: 0.095
  12. Understanding and preventing late graft loss. Transplant Proc. 2000 Nov; 32(7):1514.
    View in: PubMed
    Score: 0.088
  13. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl. 2000 Jul; 6(4):434-9.
    View in: PubMed
    Score: 0.086
  14. Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
    View in: PubMed
    Score: 0.074
  15. Kaposi's sarcoma in liver transplant recipients on FK506. Transplantation. 1998 Apr 27; 65(8):1140.
    View in: PubMed
    Score: 0.074
  16. Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
    View in: PubMed
    Score: 0.065
  17. Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience. Ann Surg. 2015 Oct; 262(4):586-601.
    View in: PubMed
    Score: 0.062
  18. Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014 Jun; 29(6):1250-7.
    View in: PubMed
    Score: 0.056
  19. Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery. 2012 Sep; 152(3):376-81.
    View in: PubMed
    Score: 0.050
  20. Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun; 24(3):1249-50.
    View in: PubMed
    Score: 0.049
  21. Deep hypothermia with circulatory arrest to aid in the management of suprahepatic vena cava stenosis after liver transplantation. Liver Transpl. 2010 Dec; 16(12):1434-6.
    View in: PubMed
    Score: 0.044
  22. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant. 2010 Sep-Oct; 24(5):701-8.
    View in: PubMed
    Score: 0.043
  23. Glucose balance of porcine liver allograft is an important predictor of outcome. J Surg Res. 2011 Dec; 171(2):851-8.
    View in: PubMed
    Score: 0.043
  24. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery. 2010 Sep; 148(3):582-8.
    View in: PubMed
    Score: 0.042
  25. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006 Aug; 30(8):986-93.
    View in: PubMed
    Score: 0.033
  26. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int. 2006 Jan; 19(1):27-37.
    View in: PubMed
    Score: 0.031
  27. [Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
    View in: PubMed
    Score: 0.029
  28. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
    View in: PubMed
    Score: 0.029
  29. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002 Sep; 81(5):333-48.
    View in: PubMed
    Score: 0.025
  30. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002 Aug; 2(7):575-80.
    View in: PubMed
    Score: 0.025
  31. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar; 2(3):287-91.
    View in: PubMed
    Score: 0.024
  32. Bacterial translocation in clinical intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1210.
    View in: PubMed
    Score: 0.022
  33. Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc. 2000 Sep; 32(6):1213.
    View in: PubMed
    Score: 0.022
  34. Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. Transplant Proc. 2000 Aug; 32(5):1109.
    View in: PubMed
    Score: 0.022
  35. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.021
  36. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation. 1999 Nov 27; 68(10):1517-25.
    View in: PubMed
    Score: 0.021
  37. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
    View in: PubMed
    Score: 0.020
  38. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg. 1999 Mar; 5(2):144-50.
    View in: PubMed
    Score: 0.020
  39. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1998 Oct 27; 66(8):1047-52.
    View in: PubMed
    Score: 0.019
  40. Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant. 2018 Oct 26; 23:751-757.
    View in: PubMed
    Score: 0.019
  41. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018 05; 102(5):727-743.
    View in: PubMed
    Score: 0.018
  42. A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. HPB (Oxford). 2018 09; 20(9):829-833.
    View in: PubMed
    Score: 0.018
  43. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
    View in: PubMed
    Score: 0.018
  44. Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
    View in: PubMed
    Score: 0.017
  45. Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc. 1997 May; 29(3):1905-6.
    View in: PubMed
    Score: 0.017
  46. Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. Gastroenterology. 1997 Apr; 112(4):1121-8.
    View in: PubMed
    Score: 0.017
  47. Evolution of a laparoscopic liver resection program: an analysis of 203 cases. Surg Endosc. 2017 10; 31(10):4150-4155.
    View in: PubMed
    Score: 0.017
  48. Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1174-7.
    View in: PubMed
    Score: 0.017
  49. Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int. 1997; 10(2):133-6.
    View in: PubMed
    Score: 0.017
  50. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg. 1996 Jan; 223(1):70-6.
    View in: PubMed
    Score: 0.016
  51. Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol. 1995 Jul-Aug; 6(4):523-9.
    View in: PubMed
    Score: 0.015
  52. Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc. 1995 Feb; 27(1):1193-4.
    View in: PubMed
    Score: 0.015
  53. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994 Jan; 219(1):40-5.
    View in: PubMed
    Score: 0.014
  54. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993 Nov 01; 72(9):2568-73.
    View in: PubMed
    Score: 0.014
  55. Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992 Sep; 216(3):223-33; discussion 233-4.
    View in: PubMed
    Score: 0.012
  56. Clinical intestinal transplantation: focus on complications. Transplant Proc. 1992 Jun; 24(3):1238-40.
    View in: PubMed
    Score: 0.012
  57. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.012
  58. Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection. Surg Endosc. 2011 Apr; 25(4):1143-7.
    View in: PubMed
    Score: 0.011
  59. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
    View in: PubMed
    Score: 0.010
  60. Comparison of laparoscopic versus open liver tumor resection: a case-controlled study. Surg Endosc. 2009 Apr; 23(4):847-53.
    View in: PubMed
    Score: 0.010
  61. Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl. 2008 Jan; 14(1):96-9.
    View in: PubMed
    Score: 0.009
  62. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl. 2008 Jan; 14(1):59-65.
    View in: PubMed
    Score: 0.009
  63. Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
    View in: PubMed
    Score: 0.009
  64. Caroli's disease and orthotopic liver transplantation. Liver Transpl. 2006 Mar; 12(3):416-21.
    View in: PubMed
    Score: 0.008
  65. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
    View in: PubMed
    Score: 0.007
  66. Preliminary report on surgical technique in hepatic parenchymal transection for liver tumors in the elderly: a lesson learned from living-related liver transplantation. J Surg Oncol. 2004 Dec 15; 88(4):229-33.
    View in: PubMed
    Score: 0.007
  67. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis. 2003 Jul 01; 37(1):17-25.
    View in: PubMed
    Score: 0.007
  68. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc. 2002 Aug; 34(5):1651-2.
    View in: PubMed
    Score: 0.006
  69. Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
    View in: PubMed
    Score: 0.006
  70. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002 Jul 15; 74(1):7-13.
    View in: PubMed
    Score: 0.006
  71. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
    View in: PubMed
    Score: 0.006
  72. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View in: PubMed
    Score: 0.006
  73. An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant. 2001 May; 1(1):47-50.
    View in: PubMed
    Score: 0.006
  74. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
    View in: PubMed
    Score: 0.005
  75. The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
    View in: PubMed
    Score: 0.005
  76. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc. 2000 Sep; 32(6):1223-4.
    View in: PubMed
    Score: 0.005
  77. Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
    View in: PubMed
    Score: 0.005
  78. Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Transplant Proc. 1999 Feb-Mar; 31(1-2):488-9.
    View in: PubMed
    Score: 0.005
  79. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation. 1999 Jan 27; 67(2):299-303.
    View in: PubMed
    Score: 0.005
  80. Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1375-7.
    View in: PubMed
    Score: 0.005
  81. Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb; 33(2):243-54.
    View in: PubMed
    Score: 0.005
  82. Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
    View in: PubMed
    Score: 0.004
  83. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc. 1997 Feb-Mar; 29(1-2):532-3.
    View in: PubMed
    Score: 0.004
  84. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
    View in: PubMed
    Score: 0.004
  85. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
    View in: PubMed
    Score: 0.004
  86. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
    View in: PubMed
    Score: 0.004
  87. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
    View in: PubMed
    Score: 0.004
  88. Management of intestinal transplantation in humans. Transplant Proc. 1992 Jun; 24(3):1243-4.
    View in: PubMed
    Score: 0.003
  89. Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc. 1990 Feb; 22(1):44-6.
    View in: PubMed
    Score: 0.003
  90. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug; 208(2):196-202.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.